Leukemia, Myeloid, Acute
1 competing product in clinical development for Leukemia, Myeloid, Acute.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen | CSPC Pharmaceutical Group Limited | Phase 2 | Recruiting | 51 |